Home | Privacy | Contact

Health Information About Merkel Cell Cancer Merkel Cell Carcinoma: Questions and Answers - National Cancer ... A fact sheet about the diagnosis and treatment of Merkel cell carcinoma, a rare type of cancer that develops just beneath the skin and in hair follicles. National Cancer Institute ... more... Merkel cell cancer - Wikipedia, the free encyclopedia Merkel cell cancer, also called Merkel cell carcinoma, trabecular cancer of the skin, [1] Apudoma of skin, or Small cell neuroepithelial tumor of the skin, is a rare and highly ... more... Merkel Cell Carcinoma Welcome! We are physicians and researchers who work on Merkel cell carcinoma (MCC), a rare and aggressive skin cancer. If you, your patient or a loved one has recently been ... more... Merkel cell - Wikipedia, the free encyclopedia Merkel cells are oval receptor cells found in the skin of vertebrates that have synaptic ... now demonstrate an epidermal origin. [5] [6]. See also. Merkel nerve ending; Merkel cell cancer more... Merkel Cell Carcinoma Treatment - National Cancer Institute Expert-reviewed information summary about the treatment of Merkel cell carcinoma. more... Merkel Cell Cancer News ImmunoGen cancer drug granted orphan drug status - Mass High Tech ImmunoGen Inc. reports the U.S. Food and Drug Administration and the EU Committee for Orphan Medicinal Products has granted orphan drug status to an ImmunoGen compound used to treat Merkel cell carcinoma (MCC). The compound, IMGN901, has shown ... read more... ImmunoGen product gets orphan drug status - Boston Globe WALTHAM - ImmunoGen Inc. said yesterday that the Food and Drug Administration and European regulators have granted the company’s potential cancer drug IMGN901 “orphan drug’’ status. Such status is given to drugs designed to treat rare ... read more... ImmunoGen Gets FDA, EU Orphan Drug Designation Status For Cancer Drug ... - RTT News (RTTNews) - Monday, ImmunoGen, Inc. (IMGN: News ), a biotechnology company, said the US Food and Drug Administration has granted orphan drug designation to its IMGN901 compound when used for the treatment of Merkel cell carcinoma, a kind of skin ... read more... ImmunoGen cancer drug gets 'orphan drug' status - MSN Money The special designation covers IMGN901's use as a treatment for Merkel cell carcinoma, which is a rare type of aggressive cancer that develops beneath the skin. Shares of Immunogen rose 38 cents, or 5.2 percent, to $7.75 in after-hours trading after ... read more... ImmunoGen, Inc. Announces Orphan Drug Designation Granted to IMGN901 ... - Forbes BusinessWire - ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops targeted anticancer products using its antibody expertise and Targeted Antibody Payload (TAP) technology, today announced that the US Food and Drug Administration ... read more...

Home | Privacy | Contact Copyright 2009 Cancermagazines.com Thumbshots previews